Skip to main content

WELLS FARGO & COMPANY/MN

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in TSHA

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$819,502
-$858,471 QoQ
Shares Held
183,334
-39.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 98.86873138643132.ToString("F0")% Shared 0.ToString("F0")% None 1.131268613568678.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. TSHA ranks #103 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $819,502 183,334
2025-12-31 $1,677,973 305,086
2025-09-30 $474,470 145,098
2025-06-30 $247,709 107,234
2025-03-31 $151,576 109,048
2024-12-31 $178,854 103,384
2024-09-30 $144,572 71,927
2024-06-30 $156,221 69,742
2024-03-31 $21,260 7,408
2023-12-31 $13,148 7,429
2023-09-30 $20,665 6,540
2023-06-30 $12,686 19,193
2023-03-31 $3,227 4,045
2022-12-31 $2,865 1,268
2022-09-30 $1,833 950
2022-06-30 $606 163
2022-03-31 $9,421 1,445
2021-12-31 $110,196 9,459
2021-03-31 $1,165,463 57,412
2020-12-31 $330,184 12,441